Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

View source ↗

Summary

A clinical trial is assessing the long-term safety of ustekinumab compared with other biologics in patients with Crohn's disease and ulcerative colitis; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Crohn Disease, Colitis, Ulcerative | Status: RECRUITING